Antibacterial Effect of Guava Leaves Extract Mouthwash Compared to Chlorhexidine Mouthwash in High Caries Risk Patients

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03773094
Collaborator
(none)
94
2
12

Study Details

Study Description

Brief Summary

This trial is to test the antibacterial effect of Guava leaves extract mouth wash compared to Chlorhexidine mouth wash in high caries risk patients.

Also salivary pH and patient satisfaction to taste will also be tested.

Condition or Disease Intervention/Treatment Phase
Phase 2/Phase 3

Detailed Description

This study is conducted to evaluate the effect of Guava leaves extract mouth wash on anti-bacterial activity against streptococcus mutans, salivary pH and patient satisfaction to taste compared to Chlorhexidine mouth wash.

P: Population with high caries risk patients I: Intervention by Guava leaves extract mouthwash C: Control is Chlorhexidine mouthwash O1: The primary outcome is antibacterial activity. O2: The secondary outcome is salivary pH O3: The tertiary outcome is patient satisfaction to taste

Study Design

Study Type:
Interventional
Anticipated Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of Guava Leaves Extract Mouth Wash on Antibacterial Activity, Salivary pH and Patient Satisfaction Compared to Chlorhexidine Mouth Wash in High Caries Risk Patients: A Randomized Control Clinical Trial
Anticipated Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Nov 1, 2019
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Guava leaves extract

A natural product that is prepared as a mouthwash

Drug: Guava leaves extract
Natural product : The leaves of the guava tree are full of antioxidants, anti-inflammatory agents, antibacterials, and even tannins that can have significant health benefits, from treating stomach troubles to chronic diseases like cancer •
Other Names:
  • Psidium guajava
  • Active Comparator: Chlorhexidine

    chemical agent Chlorhexidine as a mouthwash

    Drug: Chlorhexidine
    chemical agent used as a mouthwash against cariogenic bacteria. considered the gold standard
    Other Names:
  • Chlorhexidine glucnate
  • Outcome Measures

    Primary Outcome Measures

    1. Anti-bacterial effect against streptococcus mutans [3 months]

      Antimicrobial effect against streptococcus mutans: saliva samples collected and total bacterial count measured after agar plates incubating, expressed in colony forming units

    Secondary Outcome Measures

    1. Salivary pH [3 months]

      Saliva samples pH will be measured using digital pH meter to evaluate its efficacy in preventing the action of acidogenic bacteria in high caries risk patients. It displays numerical value.

    Other Outcome Measures

    1. Patient satisfaction to taste: questionnaire [3 months]

      The patient will fill a questionnaire to assess patient satisfaction to taste after usage of the mouthwash. Nominal answers

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria

    1. High caries risk patients

    2. 18-50 years

    3. Healthy cooperative patients

    4. Males or Females

    Exclusion Criteria

    1. Medically compromised patients

    2. Patients with any systemic disease that might affect the salivary flow

    3. Allergy to any of the ingredients

    4. Patients with physical limitations that might affect normal tooth brushing and mouth rinsing

    5. Presence of intraoral infections

    6. Currently using any mouth rinse

    7. Smokers

    8. Use of antibiotics in the previous 30 days

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Engy Mostafa Magdy Abdou Ahmed Kassem, Assistant Lecturer, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03773094
    Other Study ID Numbers:
    • Guava leaves extract CHX
    First Posted:
    Dec 12, 2018
    Last Update Posted:
    Dec 12, 2018
    Last Verified:
    Dec 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 12, 2018